Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,238.00
+7.00 (0.57%)
Feb 19, 2026, 10:45 AM IDT

TLV:REKA Balance Sheet

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
6.037.0319.3120.2118.636.89
Trading Asset Securities
0.040.040.040.080.040.04
Cash & Short-Term Investments
6.067.0719.3520.2918.6436.93
Cash Growth
63.23%-63.48%-4.63%8.83%-49.53%44.22%
Accounts Receivable
102.04127.11117.68120.71107.3787.63
Other Receivables
6.88.558.676.832.251.98
Receivables
108.84135.66126.35127.54109.6289.61
Inventory
96.5482.4896.692.289.6197.85
Prepaid Expenses
-2.631.941.831.420.71
Other Current Assets
-1.227.091.282.372.25
Total Current Assets
211.44229.05251.33243.14221.66227.35
Property, Plant & Equipment
129.49140.07154.62163.21177181.82
Long-Term Investments
1.251.181.17--1.84
Goodwill
35.1435.1435.1415.18--
Other Intangible Assets
22.0525.731.6620.6732.974.18
Long-Term Deferred Tax Assets
15.316.0710.796.225.464.5
Other Long-Term Assets
--0.010.010.010.01
Total Assets
414.67447.22484.72448.42437.09419.69
Accounts Payable
74.9787.5278.8981.2157.4459.89
Accrued Expenses
-20.9823.9517.0513.6112.96
Short-Term Debt
24.0214.353.12-0.015
Current Portion of Long-Term Debt
-15.224.830.918.9622.06
Current Portion of Leases
7.427.296.95.595.034.82
Current Income Taxes Payable
0.330.351.560.760.260.96
Current Unearned Revenue
-0.240.130.10.250.88
Other Current Liabilities
21.5812.134.453.443.041.7
Total Current Liabilities
128.32158.04143.79139.0398.61108.26
Long-Term Debt
71.9663.62110.0991.66101.2390.86
Long-Term Leases
32.1933.738.7637.5540.643.6
Pension & Post-Retirement Benefits
11.2110.589.748.869.229.38
Long-Term Deferred Tax Liabilities
4.915.276.032.753.16-
Other Long-Term Liabilities
15.6914.0220.746.4911.212
Total Liabilities
264.28285.24329.14286.34264.03254.1
Common Stock
13.6413.6413.6413.6413.6413.64
Additional Paid-In Capital
126.61126.61126.61126.61126.61126.61
Retained Earnings
9.5721.1914.6721.3532.7325.69
Treasury Stock
-0.51-0.51-0.51-0.51-0.51-0.51
Comprehensive Income & Other
1.030.991.120.930.540.09
Total Common Equity
150.35161.93155.54162.03173.01165.53
Minority Interest
0.050.050.050.050.050.06
Shareholders' Equity
150.39161.98155.59162.08173.07165.59
Total Liabilities & Equity
414.67447.22484.72448.42437.09419.69
Total Debt
135.59134.16183.66165.7165.82166.34
Net Cash (Debt)
-129.52-127.09-164.31-145.41-147.18-129.41
Net Cash Per Share
-11.08-11.13-14.39-12.74-12.89-11.34
Filing Date Shares Outstanding
11.111.4111.4111.4111.4111.41
Total Common Shares Outstanding
11.111.4111.4111.4111.4111.41
Working Capital
83.1271.01107.54104.11123.05119.09
Book Value Per Share
13.5514.1913.6314.1915.1614.50
Tangible Book Value
93.15101.0988.73126.18140.05161.35
Tangible Book Value Per Share
8.408.867.7711.0512.2714.14
Land
-1.891.892.072.072.07
Buildings
-119.29117.94124.71122.66119.21
Machinery
-125.12121.03112.99109.84106.6
Leasehold Improvements
-63.1661.1558.2857.2354.74
Source: S&P Global Market Intelligence. Standard template. Financial Sources.